Biotricity(NASDAQ:BTCY) 
Biotricity, Inc., medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and...
Website: http://www.biotricity.com
Founded: 2012
CEO: Waqaas Al-Siddiq
Sector: Healthcare
Industry: Medical Devices
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2016-12-31 | 2016-06-30 | 2016-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 11,747,607 | 7,759,788 | 3,873,993 | 3,702,597 | 3,619,108 | 3,266,846 | 3,201,743 | 3,178,311 | 2,972,972 | 2,891,297 | 3,020,765 | 2,459,181 | 2,381,389 | 2,056,052 | 1,930,108 | 1,807,309 | 1,764,110 | 1,187,033 | 1,001,252 | 744,585 | 451,898 | 362,920 | 381,899 | 345,906 | 327,000 | 178,140 | 117,640 | 84,760 | 17,660 | |||||||||
yoy | 224.60% | 137.53% | 21.00% | 16.50% | 21.73% | 12.99% | 5.99% | 20.89% | 21.41% | 46.92% | 27.41% | 31.76% | 16.55% | 92.77% | 142.73% | 290.38% | 227.08% | 162.18% | 115.26% | 38.20% | 103.73% | 224.63% | 308.10% | 1751.64% | ||||||||||||||
qoq | 51.39% | 100.30% | 4.63% | 2.31% | 10.78% | 2.03% | 0.74% | 6.91% | 2.82% | -4.29% | 3.27% | 15.82% | 6.79% | 2.45% | 48.62% | 18.55% | 34.47% | 64.77% | 24.52% | -4.97% | 10.41% | 5.78% | 83.56% | 51.43% | 38.79% | 379.95% | ||||||||||||
cost of revenue | 2,197,833 | 1,461,490 | 757,193 | 724,416 | 855,140 | 807,672 | 838,575 | 905,998 | 804,986 | 892,019 | 1,104,061 | 1,057,215 | 1,101,152 | 830,923 | 1,105,271 | 672,711 | 525,426 | 750,690 | 508,877 | 420,096 | 191,462 | 398,187 | 100,782 | 114,216 | 112,086 | 164,242 | 27,504 | 47,118 | ||||||||||
gross profit | 9,549,774 | 6,298,298 | 3,116,800 | 2,978,181 | 2,763,968 | 2,459,174 | 2,363,168 | 1,916,704 | 1,225,129 | 824,837 | 260,436 | |||||||||||||||||||||||||||
yoy | 245.51% | 156.11% | 31.89% | 23.29% | 56.45% | |||||||||||||||||||||||||||||||||
qoq | 51.62% | 102.08% | 4.65% | 7.75% | 12.39% | 4.06% | ||||||||||||||||||||||||||||||||
gross margin % | 81.29% | 81.17% | 80.45% | 80.43% | 76.37% | 75.28% | 73.81% | 0% | 0% | 0% | 63.45% | NaN% | 0% | 0% | 59.59% | NaN% | 42.74% | 0% | 0% | 0% | 0% | 0% | 57.63% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% |
expenses | ||||||||||||||||||||||||||||||||||||||
selling, general and administrative expenses | 6,630,567 | 4,443,573 | 2,138,692 | 3,261,080 | 2,381,734 | 2,248,864 | 2,966,119 | 3,520,215 | ||||||||||||||||||||||||||||||
research and development expenses | 1,922,528 | 1,298,961 | 696,163 | 572,567 | 551,216 | 517,982 | 513,895 | 708,275 | 452,956 | 697,620 | 712,975 | 876,460 | 828,914 | 821,176 | 900,499 | 625,638 | 588,997 | 551,496 | 681,411 | 402,340 | 423,883 | 483,574 | 447,639 | 218,525 | 213,496 | 393,545 | 401,271 | 187,859 | 309,871 | 655,903 | 377,924 | 413,624 | 315,110 | 266,370 | 241,534 | |||
total operating expenses | 8,553,095 | 5,742,534 | 2,834,855 | 3,833,647 | 2,932,950 | 2,766,846 | 3,480,014 | 5,316,649 | 3,449,760 | 4,184,951 | 4,233,190 | 5,653,826 | 5,712,775 | 5,702,179 | 5,560,137 | 6,303,424 | 4,241,200 | 3,682,504 | 4,370,279 | 3,183,538 | 3,629,116 | 4,451,252 | 2,627,567 | 2,239,804 | 2,304,515 | 1,836,458 | 2,262,384 | 2,214,382 | 2,438,176 | 2,791,474 | 2,095,590 | 1,454,899 | 1,381,769 | 800,808 | 576,620 | |||
profit from operations | 996,679 | 555,764 | 281,945 | |||||||||||||||||||||||||||||||||||
other income | 134,023 | 13,435 | 19,433 | |||||||||||||||||||||||||||||||||||
interest expense | -2,521,012 | -1,710,673 | -850,254 | -592,571.5 | -849,538 | -752,075 | -768,673 | -660,512 | ||||||||||||||||||||||||||||||
gain upon convertible promissory notes conversion and redemption [note 5] | 19,842 | |||||||||||||||||||||||||||||||||||||
accretion and amortization expenses | -541,183 | -355,713 | ||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities [note 8] | -168,306 | -33,971 | -25,200 | -117,070 | 32,339 | -193,757 | -306,862 | 253,791 | -326,683 | -18,783 | 101,452 | -99,705 | 172,042 | 198,224 | 774,773 | |||||||||||||||||||||||
net loss before income taxes | -2,079,957 | -1,362,890 | -671,977 | -1,935,737 | -1,229,154 | -1,561,768 | -3,694,520 | -4,182,470 | -2,808,091 | -3,690,840 | -3,412,882 | -4,517,115 | -4,692,548 | -4,776,252 | -7,109,649 | -10,752,890 | -5,656,099 | -5,471,545 | -3,900,245 | -2,962,207 | -3,157,179 | -4,598,222 | -2,371,005 | -2,008,114 | -2,089,601 | -1,822,560 | -2,172,248 | -2,176,740 | -2,420,516 | -2,791,474 | -2,095,590 | -1,454,899 | -2,303,313 | -1,044,607 | -1,269,151 | |||
income taxes | ||||||||||||||||||||||||||||||||||||||
net loss before dividends | -2,079,957 | -1,362,890 | -671,977 | -1,935,737 | -1,229,154 | -1,561,768 | -3,694,520 | -4,182,470 | -2,808,091 | -3,690,840 | -3,412,882 | -4,517,115 | -4,692,548 | -4,776,252 | -7,109,649 | -10,752,890 | -5,656,099 | -4,598,223 | -2,371,005 | |||||||||||||||||||
preferred stock dividends | -594,726 | -163,726 | -82,316 | -86,396 | -89,392 | -91,261 | -199,092 | |||||||||||||||||||||||||||||||
deemed dividend | ||||||||||||||||||||||||||||||||||||||
accretion to series b preferred shares | ||||||||||||||||||||||||||||||||||||||
net loss attributable to common stockholders | -2,674,683 | -754,293 | -2,022,133 | -1,318,546 | -1,653,029 | -6,948,292 | -3,601,579 | -5,024,389 | -7,342,871 | -1,623,097.75 | -2,394,676 | |||||||||||||||||||||||||||
translation adjustment | -41,430 | -26,883 | -36,169 | 142,527 | 76,680 | -129,376 | 23,583 | 284,266 | -204,501 | 281,240 | -175,830 | -72,823 | 465,517 | 233,004 | -20,064 | 11,663 | 6,560 | 35,874 | 366,788 | -74,540 | -105,001 | 171,391 | -234,820 | -16,329 | -22,586 | -344,268 | 222,217 | 112,866 | -102,649 | -35,974 | -23,424 | -83,858 | -86,490 | -129,591 | -61,518 | |||
comprehensive loss | -2,716,113 | -1,553,499 | -790,462 | -1,879,606 | -1,241,866 | -1,782,405 | -6,924,709 | -4,115,838 | -3,250,496 | -3,600,042 | -3,777,409 | -4,820,312 | -4,438,850 | -4,791,385 | -7,362,935 | -10,985,827 | -5,890,803 | -5,748,482 | -3,752,361 | -3,229,964 | -3,499,395 | -4,661,087 | -2,629,496 | -2,024,443 | -2,112,187 | -2,166,828 | -1,950,031 | -2,063,874 | -2,523,165 | -2,827,448 | -2,119,014 | -1,538,757 | -2,389,803 | |||||
loss per share, basic and diluted | -0.099 | -0.057 | -0.029 | -0.057 | -0.054 | -0.073 | -0.49 | -0.469 | -0.339 | -0.441 | -0.069 | -0.091 | -0.094 | -0.098 | -0.149 | -0.256 | -0.151 | -0.15 | -0.111 | -0.085 | -0.9 | -0.134 | -0.066 | -0.056 | -0.06 | -0.051 | -0.064 | -0.066 | -0.076 | -0.1 | -0.068 | -0.048 | -0.084 | -0.042 | -0.051 | |||
weighted-average number of common shares outstanding | 26,883,125 | 26,767,370 | 26,284,734 | 21,524,884 | 24,232,369 | 22,493,626 | 14,169,441 | 8,991,766 | 8,979,430 | 8,795,742 | 52,514,582 | 51,957,841 | 52,142,669 | 52,019,359 | 45,449,720 | 39,095,637 | 37,522,978 | 37,172,815 | 36,768,299 | 36,176,520 | 35,659,133 | 35,397,458 | 32,819,848 | 31,945,349 | 30,799,342 | 30,590,667 | 27,512,483 | 24,999,978 | ||||||||||
other income [note 3] | 173,270 | -11,032 | -8,637 | -9,608 | -7,359 | |||||||||||||||||||||||||||||||||
gain upon convertible promissory notes conversion and redemption [note 8] | 8,433 | |||||||||||||||||||||||||||||||||||||
net loss attributable to common stocklholders | -1,526,616 | -2,632,214 | -3,045,995 | -3,881,282 | -4,747,489 | -4,904,367 | -10,997,490 | -5,897,363 | ||||||||||||||||||||||||||||||
operating expenses | ||||||||||||||||||||||||||||||||||||||
accretion and amortization expenses [note 5,6] | -153,572 | -443,936 | -291,128 | -339,888 | -1,144,728 | -394,086.25 | -422,706 | -596,420 | -557,219 | |||||||||||||||||||||||||||||
gain upon convertible promissory notes conversion and redemption [note 9] | 8,433 | -37,414.5 | -17,357 | -4,690 | -127,611 | 6,448 | ||||||||||||||||||||||||||||||||
other income [note 9] | 66,671 | -31,993.5 | 65,512 | 36,314 | -229,800 | |||||||||||||||||||||||||||||||||
income taxes [note 3] | ||||||||||||||||||||||||||||||||||||||
deemed dividends [note 9] | -3,054,680 | |||||||||||||||||||||||||||||||||||||
income from operations | -855,466 | -168,982 | -307,672 | -1,116,846 | -3,044,336 | -1,281,774 | -2,185,673 | -2,316,486 | -4,251,860 | |||||||||||||||||||||||||||||
yoy | -71.90% | -86.82% | -85.92% | -51.79% | -69.85% | |||||||||||||||||||||||||||||||||
qoq | 406.25% | -45.08% | -72.45% | -63.31% | 137.51% | -41.36% | -5.65% | |||||||||||||||||||||||||||||||
operating margin % | 0% | 0% | 0% | -23.10% | -4.67% | -9.42% | -34.88% | -95.78% | -43.11% | -75.59% | -76.69% | NaN% | -172.90% | 0% | 0% | NaN% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% |
net revenue | 1,520,992 | 2,167,986 | 1,999,278 | 1,401,966 | 1,280,237 | 1,134,598 | 1,238,684 | 269,324.75 | 492,375 | 324,489 | 181,930.25 | 281,117 | 231,690 | 214,914 | 13,898 | 90,136 | 37,642 | |||||||||||||||||||||
selling. general and administrative expenses | 2,501,087.5 | 2,996,804 | 3,487,331 | |||||||||||||||||||||||||||||||||||
interest expense [note 5, 6 and 9] | -550,965 | -790,080 | -753,268 | |||||||||||||||||||||||||||||||||||
gain upon convertible promissory notes conversion and redemption | 3,820 | 2,148 | 6,684 | |||||||||||||||||||||||||||||||||||
other income [note 13] | -29,735.25 | 11,004 | ||||||||||||||||||||||||||||||||||||
adjustment: preferred stock dividends | -154,260.75 | -237,904 | -190,442 | -188,697 | -230,374 | |||||||||||||||||||||||||||||||||
other income/ | -143,380 | |||||||||||||||||||||||||||||||||||||
loss per share, basic | -0.069 | |||||||||||||||||||||||||||||||||||||
weighted-average number of common shares outstanding - basic | 52,514,582 | |||||||||||||||||||||||||||||||||||||
general and administrative expenses [notes 5, 6, 9 and 10] | 4,777,366 | |||||||||||||||||||||||||||||||||||||
other income [note 3, 5] | -119,880 | |||||||||||||||||||||||||||||||||||||
gain upon convertible notes conversion and repayment [note 5 and 9 (d)] | 5,391 | |||||||||||||||||||||||||||||||||||||
accretion and amortization expenses [note 6] | -51,061 | 50,839 | 50,070 | |||||||||||||||||||||||||||||||||||
general and administrative expenses [notes 5,6, 8, 9 and 10] | 4,883,861 | |||||||||||||||||||||||||||||||||||||
other expense [note 8] | -2,891 | 816,929 | ||||||||||||||||||||||||||||||||||||
loss upon convertible promissory notes conversion [note 5 and 9 (c)] | 40,020 | |||||||||||||||||||||||||||||||||||||
less: preferred stock dividends | 211,819 | 248,137 | 233,222 | 244,600 | 241,264 | 5,917.75 | 23,671 | |||||||||||||||||||||||||||||||
general and administrative expenses [notes 8, 9 and 10] | 4,881,003 | 4,659,638 | ||||||||||||||||||||||||||||||||||||
other expense | ||||||||||||||||||||||||||||||||||||||
loss upon convertible promissory notes conversion [note 9] | 50,908 | |||||||||||||||||||||||||||||||||||||
weighted average number of common shares outstanding | 51,440,944 | 49,168,264 | 42,928,242 | 37,256,315 | 33,892,765 | |||||||||||||||||||||||||||||||||
other expense [note 8] [note 9] | 264,734 | |||||||||||||||||||||||||||||||||||||
accretion and amortization expenses [note 5] [note 6] | 1,334,842 | |||||||||||||||||||||||||||||||||||||
general and administrative expenses [notes 7, 8 and 9] | 5,677,786 | 3,652,203 | 2,418,824.75 | 3,688,868 | 2,781,198 | 3,205,233 | 1,573,056.25 | 2,179,928 | 2,021,279 | 2,091,019 | 1,503,985.5 | 1,861,113 | 2,026,523 | 2,128,305 | 956,400.5 | 1,717,666 | 1,041,275 | 1,066,659 | ||||||||||||||||||||
accretion and amortization expenses [note 5] | 5,164,719 | 2,335,167 | ||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities [note 7] | -397,584 | -204,142 | ||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities [note 7 ] | 298,983 | |||||||||||||||||||||||||||||||||||||
accretion and amortization expense [note 5] | 180,698.75 | 380,692 | 342,103 | |||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities [note 6] | -195,798.25 | -349,714 | -229,337 | 62,284 | -1,503 | 42,128 | ||||||||||||||||||||||||||||||||
net income | -2,504,907.75 | -3,900,246 | -2,962,207 | -3,157,179 | -2,008,114 | -2,089,601 | -1,822,560 | -2,172,248 | -2,176,740 | -2,420,516 | -2,791,474 | -2,095,590 | -1,454,899 | -2,303,313 | -1,044,607 | -1,269,151 | ||||||||||||||||||||||
yoy | 47.51% | 51.09% | -7.75% | -13.67% | -34.71% | 3.66% | 49.61% | 5.09% | 100.61% | 14.64% | ||||||||||||||||||||||||||||
qoq | -35.78% | 31.67% | -6.18% | -3.90% | 14.65% | -16.10% | -0.21% | -10.07% | -13.29% | 33.21% | 44.04% | -36.83% | -17.69% | |||||||||||||||||||||||||
net income margin % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | NaN% | 0% | 0% | 0% | NaN% | 0% | 0% | 0% | -211.02% | -389.54% | -397.83% | -698.65% | 0% | 0% | -580.54% | -639.02% | -1023.11% | -1846.52% | -2568.12% | -13706.21% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | NaN% | -Infinity% | -Infinity% |
less: preferred stock dividends [note 8] | 162,334 | 218,904 | 193,217 | 237,215 | ||||||||||||||||||||||||||||||||||
net loss attributed to common stockholders | -2,667,242 | -4,119,149 | -3,155,424 | -3,394,394 | ||||||||||||||||||||||||||||||||||
accretion expense [note 5] | 66,358 | 26,058 | 879,416 | |||||||||||||||||||||||||||||||||||
see accompanying notes to unaudited condensed consolidated interim financial statements | ||||||||||||||||||||||||||||||||||||||
see accompanying notes to the condensed consolidated interim financial statements | ||||||||||||||||||||||||||||||||||||||
accretion expense including day one derivative loss [note 5] | 219,854 | |||||||||||||||||||||||||||||||||||||
general and administrative expenses | 534,438 | 335,086 | ||||||||||||||||||||||||||||||||||||
accretion expense | 120,531 | 73,572 | ||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities | 123,268 | 618,959 | ||||||||||||||||||||||||||||||||||||
net loss and comprehensive loss | -1,174,198 | -1,330,669 | ||||||||||||||||||||||||||||||||||||
weighted-average number of common and exchangeable shares outstanding | 35,956,180 | 33,376,068 | 30,165,638 | 25,813,228 | 24,999,978 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2022-06-30 | 2021-12-31 | 2021-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2015-11-30 | 2015-08-31 | 2015-05-31 |
|---|---|---|---|---|---|---|---|---|---|---|
current assets | ||||||||||
cash | 308,460 | 7,207,974 | 16,790,346 | 11,694,463 | 202,653 | 843,643 | 2,482,262 | 1,838 | 4,410 | |
accounts receivable | 2,099,065 | 1,826,920 | 1,989,063 | 1,643,223 | 4,800 | |||||
inventory [note 3] | 2,256,289 | |||||||||
deposits and other receivables | 872,420 | 380,592 | 470,622 | 490,683 | 5,200 | 17,046 | 29,682 | |||
total current assets | 5,536,234 | 10,846,540 | 19,609,865 | 13,946,460 | 253,630 | 896,426 | 2,539,935 | 11,042 | 18,748 | 800 |
deposits and other receivables [note 12] | 109,297 | |||||||||
long-term accounts receivable | 83,939 | 2,723 | 5,846 | |||||||
property and equipment [note 13] | 6,622 | |||||||||
operating right of use assets [note 12] | 586,680 | |||||||||
total assets | 6,322,772 | 12,149,679 | 21,045,495 | 13,952,306 | 286,630 | 929,426 | 2,572,935 | 11,042 | 18,748 | 28,000 |
current liabilities | ||||||||||
accounts payable and accrued liabilities [note 4] | 7,908,201 | 2,701,077 | 2,916,973 | 2,690,577 | 1,006,440 | 756,179 | 630,089 | |||
convertible promissory notes and short term loans [note 5] | 10,394,614 | 1,238,000 | 1,138,014 | 1,831,184 | ||||||
term loan, current | 2,400,000 | |||||||||
derivative liabilities [note 8] | 443,583 | 419,332 | 572,005 | |||||||
advance from customers | 1,895,920 | |||||||||
operating lease obligations, current [note 10] | 571,706 | |||||||||
total current liabilities | 23,614,024 | 4,577,442 | 4,828,844 | 5,214,505 | ||||||
federally guaranteed loans [note 7] | 870,800 | 870,800 | 870,800 | |||||||
term loan [note 6] | 12,015,626 | 11,662,742 | 11,563,363 | |||||||
operating lease obligations | 102,307 | |||||||||
total liabilities | 37,984,860 | 18,710,097 | 18,726,424 | 6,207,123 | 1,006,440 | 756,179 | 630,089 | 302,528 | 262,322 | 262,185 |
mezzanine equity | ||||||||||
series b convertible redeemable preferred stock, 0.001 par value... | 1,750,290 | |||||||||
stockholders’ equity | ||||||||||
preferred stock, 0.001 par value... | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||
series a preferred stock, 0.001 par value... | ||||||||||
common stock, 0.001 par value... | 26,953 | 51,686 | 49,657 | 48,876 | 32,312 | 31,858 | 31,531 | 9,000 | 9,000 | 4,500 |
shares to be issued 581,599 and 324,276 shares of common stock as at september 30, 2025 and march 31, 2025, respectively [note 9] | 284,244 | |||||||||
additional paid-in-capital | 107,278,101 | 91,912,772 | 85,874,483 | 84,893,876 | 28,685,030 | 27,161,984 | 25,594,234 | |||
accumulated other comprehensive loss | -33,276 | -535,652 | -636,027 | -615,963 | -745,778 | -643,129 | -628,694 | |||
accumulated deficit | -140,968,401 | -98,061,531 | -87,055,411 | -79,712,541 | -28,867,947 | -26,447,430 | -23,655,955 | -313,786 | ||
total stockholders’ equity | -33,412,378 | -6,560,418 | 2,319,071 | 7,745,183 | 173,247 | -291,486 | -243,574 | -234,185 | ||
total liabilities, mezzanine and stockholders’ deficiency | 6,322,772 | |||||||||
inventory | 1,431,054 | 359,834 | 118,091 | |||||||
deposits | 85,000 | |||||||||
property and equipment [note 11] | 25,970 | |||||||||
operating right-of-use lease asset [note 10] | 1,192,169 | 1,370,960 | ||||||||
operating lease liability [note 10] | 219,033 | 201,852 | ||||||||
stockholders’ deficiency | ||||||||||
preferred stock | 1 | 1 | ||||||||
shares to be issued 95,515 and 123,817 shares of common stock as at june 30, 2022 and march 31, 2022, respectively) [note 9] | 72,299 | |||||||||
total liabilities and stockholders’ deficiency | 12,149,679 | 21,045,495 | ||||||||
property, plant and equipment | 28,947 | |||||||||
preferred stock, value | 1 | |||||||||
shares to be issued 1,233,329 and 268,402 shares of common stock as at december 31, 2021 and march 31, 2021, respectively) [note 9] | 4,086,361 | |||||||||
operating right of use lease asset [note 9] | ||||||||||
derivative liabilities [note 7] | 692,744 | |||||||||
operating lease liability [note 9] | ||||||||||
federally guaranteed loans [note 6] | 870,800 | |||||||||
shares to be issued (1,014,303 and 268,402 shares of common stock as at september 30, 2021 and march 31, 2021, respectively) [note 8] | 3,130,926 | |||||||||
total liabilities and stockholders’ equity | 13,952,306 | 11,042 | 18,748 | 28,000 | ||||||
harmonized sales tax recoverable | 40,977 | 35,737 | 27,991 | |||||||
convertible promissory notes [note 5] | ||||||||||
derivative liabilities [note 6] | ||||||||||
stockholders' equity | ||||||||||
shares to be issued [note 7] | 176,572 | 601,729 | ||||||||
total stockholders' equity | -719,810 | 1,942,846 | ||||||||
total liabilities and stockholders' equity | 286,630 | 929,426 | 2,572,935 | |||||||
commitments and contingencies [note 9] | ||||||||||
subsequent events [note 10] | ||||||||||
see accompanying notes to condensed consolidated interim financial statements | ||||||||||
non-current assets | ||||||||||
shares to be issued (20,250 shares of common stock) [note 7] | 69,963 | |||||||||
commitments [note 9] | ||||||||||
assets | ||||||||||
current assets: | ||||||||||
prepaid expense and other | 9,204 | 14,338 | 800 | |||||||
other assets: | ||||||||||
deferred offering expense | 27,200 | |||||||||
intangible asset | ||||||||||
total other assets | 27,200 | |||||||||
liabilities and stockholders’ equity | ||||||||||
current liabilities: | ||||||||||
accounts payable | 203,125 | 180,650 | 172,450 | |||||||
accrued compensation | 52,500 | 48,000 | 43,500 | |||||||
loans – unrelated parties | 46,903 | 33,672 | 46,235 | |||||||
additional paid in capital | 13,300 | 13,300 | ||||||||
deficit accumulated during development stage | -265,874 | -238,685 | ||||||||
loan – related party |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2023-03-31 | 2022-03-31 | 2015-11-30 |
|---|---|---|---|---|
cash flows from operating activities | ||||
net loss | -717,067 | -47,912 | ||
adjustments to reconcile net loss to net cash from operations | ||||
stock based compensation | 6,001 | 281,978 | 487,333 | |
issuance of shares for services | 0 | 447,357 | ||
issuance of warrants for services, at fair value | ||||
accretion and amortization expenses | 185,470 | |||
change in fair value of derivative liabilities | 134,335 | 13,902 | 7,377 | |
loss on debt and share conversion and redemption | ||||
property, plant and equipment depreciation | 1,488 | |||
right of use assets amortization | ||||
changes in operating assets and liabilities: | ||||
accounts receivable | 482,337 | 726,996 | -14,892 | |
inventory | 281,531 | -483,090 | ||
deposits and other receivables | -299,435 | -152,942 | 116,293 | |
advance from customers | -1,150,000 | |||
accounts payable and accrued liabilities | 167,767 | 1,410,272 | -355,508 | |
net cash generated (used) in operating activities | -740,291 | |||
cash flows from investing activities | ||||
not shown on actual cash flow statement | ||||
property, plant and equipment | ||||
net cash from investing activities | -1 | |||
cash flows from financing activities | ||||
issuance of common shares | 0 | |||
issuance of preferred shares | 0 | |||
redemption of preferred shares | 0 | 0 | 0 | |
proceeds from (repayment to) convertible debentures | ||||
proceeds from (repayment to) short term loan and promissory notes | 804,328 | |||
term loan | 0 | |||
preferred stock dividend | -6,000 | -6,049 | -198,148 | |
net cash provided (used) in financing activities | 721,325 | |||
effect of foreign currency translation | -33,137 | -177 | -123,495 | |
net decrease in cash during the period | ||||
cash, beginning of period | 0 | |||
cash, end of period | -52,103 | |||
supplemental disclosure of cash flow information: | ||||
cash paid for interest | 810,339 | |||
cash paid for taxes | ||||
loss on debt conversion and redemption | ||||
non cash lease expense | ||||
net increase in cash during the period | ||||
net loss before dividends | -4,672,228 | |||
accretion and amortization expense | ||||
loss upon convertible promissory notes conversion and redemption | ||||
loss on debt and warrant modification [note 5] | ||||
property and equipment depreciation | 1,488 | |||
non-cash lease expenses | ||||
inventories | ||||
net cash from operating activities | -1,878,268 | -4,755,101 | -15,803 | |
capital expenditures | 0 | 0 | 0 | |
free cash flows | -1,878,268 | -4,755,101 | -15,803 | |
property and equipment | ||||
exercise of warrants for cash | 0 | 353,328 | ||
federally guaranteed loans | 0 | |||
proceeds from convertible notes | ||||
proceeds from (repayment of) promissory note and short term loan | ||||
issuance of shares from uplisting | 0 | |||
net cash from financing activities | 1,997,484 | 155,180 | 13,231 | |
net increase in cash during the year | ||||
cash, beginning of year | ||||
cash, end of year | ||||
interest paid | ||||
taxes | ||||
adjustments to reconcile net loss to net cash from operations: | ||||
issuance of warrants for services | ||||
loss upon convertible promissory notes and preferred stock conversions | ||||
loss on debt and warrant modification | ||||
repayment of convertible debentures and notes | ||||
proceeds from short term loan and promissory notes | ||||
loss on debt conversion | ||||
gain on forgiveness of federally guaranteed loans | ||||
lease expenses | ||||
issuance of convertible debentures | ||||
repayment to promissory note and short term loan | ||||
supplementary | ||||
loss on debt and preferred stock conversion | ||||
proceeds from (repayment to) convertible notes | ||||
proceeds pursuant to term loan | ||||
cash flow from operating activities: | ||||
amortization | ||||
shares issued for organizational expense | ||||
adjustments to reconcile net loss to cash from operating activities: | ||||
change in prepaid expenses and other | 5,134 | |||
change in deferred offering expense | ||||
change in accounts payable | 22,475 | |||
change in accrued compensation | 4,500 | |||
change in deferred expenses | ||||
cash flow from investing activities | ||||
cash flow from financing activities: | ||||
proceeds from sale of common stock | ||||
deferred offering costs paid in cash | ||||
loans from unrelated parties | 14,231 | |||
payment of loans unrelated parties | -1,000 | |||
change in cash | -2,572 | |||
cash at beginning of period | 4,410 | |||
cash at end of period | 1,838 | |||
supplemental disclosure of cash flow information | ||||
cash paid for: | ||||
interest | ||||
income taxes | ||||
non-cash investing and financing activities: | ||||
stock issued for intangible asset |